EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED

Company number SC005534

Date	Type	Description	View / Download
18 Mar 2020	TM01	Termination of appointment of Charalampos Panagiotidis as a director on 2 March 2020	(1 page)
18 Mar 2020	TM01	Termination of appointment of James Borger as a director on 2 March 2020	(1 page)
20 Feb 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/19	(3 pages)
20 Feb 2020	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/19	(1 page)
18 Feb 2020	AP02	Appointment of The Wellcome Foundation Limited as a director on 17 February 2020	(2 pages)
12 Sep 2019	CS01	Confirmation statement made on 1 September 2019 with no updates	(3 pages)
25 Jun 2019	AA	Full accounts made up to 31 December 2018	(18 pages)
07 May 2019	TM01	Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019	(1 page)
04 Apr 2019	TM01	Termination of appointment of Alan George Burns as a director on 3 April 2019	(1 page)
13 Mar 2019	AP01	Appointment of Mr James Borger as a director on 25 February 2019	(2 pages)
12 Mar 2019	AP01	Appointment of Mr Charalampos Panagiotidis as a director on 15 February 2019	(2 pages)
18 Feb 2019	TM01	Termination of appointment of Oleg Dubianskij as a director on 13 February 2019	(1 page)
19 Sep 2018	CS01	Confirmation statement made on 1 September 2018 with no updates	(3 pages)
28 Mar 2018	AA	Full accounts made up to 31 December 2017	(14 pages)
15 Sep 2017	CS01	Confirmation statement made on 1 September 2017 with no updates	(3 pages)
11 Apr 2017	AA	Full accounts made up to 31 December 2016	(14 pages)
06 Feb 2017	AP01	Appointment of Mr Oleg Dubianskij as a director on 31 January 2017	(2 pages)
08 Sep 2016	CS01	Confirmation statement made on 1 September 2016 with updates	(5 pages)
26 Jun 2016	AA	Full accounts made up to 31 December 2015	(16 pages)
29 Sep 2015	AR01	Annual return made up to 1 September 2015 with full list of shareholders Statement of capital on 2015-09-29 GBP 1,315,000	(7 pages)
30 May 2015	AA	Full accounts made up to 31 December 2014	(12 pages)
11 Sep 2014	AR01	Annual return made up to 1 September 2014 with full list of shareholders Statement of capital on 2014-09-11 GBP 1,315,000	(7 pages)
25 Feb 2014	AA	Accounts for a dormant company made up to 31 December 2013	(8 pages)
24 Sep 2013	AR01	Annual return made up to 1 September 2013 with full list of shareholders Statement of capital on 2013-09-24 GBP 1,315,000	(7 pages)
23 Sep 2013	CH02	Director's details changed for Glaxo Group Limited on 8 March 2013	(2 pages)